Pancreatic Cancer Research

ResearcherFox Chase Cancer CenterNo recent work listed

Carolyn Y. Fang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0575-3867; OpenAlex author ID A5086232315. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 trial · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 1

  1. Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2020.08.015↗

Trials 1

  1. A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients Principal investigator NCT02442323↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ralph A. Francescone III · 1 shared paper, 2020 · strength 0.08
  2. Charline Ogier · 1 shared paper, 2020 · strength 0.08
  3. Linara Gabitova-Cornell · 1 shared paper, 2020 · strength 0.08
  4. Alana M. O’Reilly · 1 shared paper, 2020 · strength 0.08
  5. Richard A. Moffitt · 1 shared paper, 2020 · strength 0.08
  6. Janusz Franco‐Barraza · 1 shared paper, 2020 · strength 0.08
  7. Edna Cukierman · 1 shared paper, 2020 · strength 0.08
  8. Igor A. Astsaturov · 1 shared paper, 2020 · strength 0.08
  9. Erica A. Golemis · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.